Conclusions:
Itraconazole was comparable to Methylprednisolone in preventing disease recurrence in the post-operative management of AFRS. It may be a viable alternative to replace systemic steroids where the latter may be contraindicated. An oral dose of 400 mg once daily of Itraconazole given for six weeks was safe.
Funding Source : There was no funding from any external agency.
Conflict of interest: None to declare.